Lifecare ASA: Mandatory notification of trade

13 Mar 2026 23:37 CET

The Company has been informed that Hannibal Invest AS, a company closely
associated with Hans Hekland, board member and primary insider of Lifecare
ASA, has sold 211,856 shares in the Company at a price of NOK 0.4456 per
share.

Following this transaction, Hannibal Invest AS holds 746,302 shares and
705,196 Warrants Series 2 in the Company.

About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring systems to market. Lifecare
enables osmotic pressure as sensing principle. Lifecare's sensor technology is
suitable for identifying and monitoring the occurrence of a wide range of
analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR. The information was submitted for publication, through the
agency of the contact persons set out above, at 2026-03-13 23:37 CET.

More information:
Access the news on Oslo Bors NewsWeb site

668351_Lifecare ASA- Mandatory notification of trade.pdf
668351_260313 PDMR Attachment Hannibal Invest Shares.pdf